Home>
US Stocks>
Charles River Laboratories International

Charles River Laboratories International share price today

(CRL)

Charles River Laboratories International share price is $186.65 & ₹15,915.65 as on 27 Dec 2024, 2.30 'hrs' IST

$186.65

▲

0.36

(0.19%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Charles River Laboratories International share price in Dollar and Rupees. Guide to invest in Charles River Laboratories International from India. Also see the sentimental analysis on Indian investors investing in Charles River Laboratories International. Get details on the Indian mutual funds that are investing in Charles River Laboratories International. Get Analyst recommendations and forecasts along with all the Charles River Laboratories International's financials.

Charles River Laboratories International share price movements

Today's Low: $184.49
Today's High: $187.18
$186.65
1.16%
Downside
Day's Volatility :1.44%
Upside
0.28%
52 Weeks Low: $176.48
52 Weeks High: $275.00
$186.65
5.45%
Downside
52 Weeks Volatility :35.83%
Upside
32.13%

Charles River Laboratories International Returns

Period	Charles River Laboratories International	Sector (Health Care)	Index (Russel 2000)
3 Months	-6.06%	-9.0%	0.0%
6 Months	-9.82%	-4.6%	0.0%
1 Year	-21.98%	3.0%	0.0%
3 Years	-49.92%	0.0%	-21.1%

Charles River Laboratories International Key Statistics

in dollars & INR

Previous Close	$186.29
Open	$184.89
Today's High	$187.18
Today's Low	$184.487
Market Capitalization	$9.5B
Today's Volume	$231.1K
52 Week High	$275.0
52 Week Low	$176.48
Revenue TTM	$4.1B
EBITDA	$948.8M
Earnings Per Share (EPS)	$8.01
PE Ratio	23.26
Profit Margin	10.44%
Quarterly Earnings Growth YOY	-0.21%
Return On Equity TTM	11.92%

How to invest in Charles River Laboratories International from India?

It is very easy for Indian residents to invest directly in Charles River Laboratories International from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Charles River Laboratories International stock in both Indian Rupees (INR) and US Dollars (USD). Search for Charles River Laboratories International or CRL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Charles River Laboratories International or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Charles River Laboratories International shares which would translate to 0.005 fractional shares of Charles River Laboratories International as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Charles River Laboratories International, in just a few clicks!

Returns in Charles River Laboratories International for Indian investors in Rupees

Investment Value

₹1,00,000

Charles River Laboratories International investment value today

Current value as on today

₹80,493

Returns

₹19,507

(-19.51%)

Returns from Charles River Laboratories International Stock

₹21,832 (-21.83%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Charles River Laboratories International

-18%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Charles River Laboratories International on INDmoney from India has reduced in the last 30 days as on Dec 27, 2024. -18% less investors are searching Charles River Laboratories International in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Charles River Laboratories International

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	444	0.40	0.02%

Global Institutional Holdings in Charles River Laboratories International

Vanguard Group Inc
11.93%
BlackRock Inc
9.95%
Wellington Management Company LLP
7.32%
State Street Corp
4.17%
Kayne Anderson Rudnick Investment Management LLC
3.79%
Allspring Global Investments Holdings, LLC
3.44%

Analyst Recommendation on Charles River Laboratories International

Buy

61%Buy

38%Hold

0%Sell

Based on 21 Wall street analysts offering stock ratings for Charles River Laboratories International(by analysts ranked 0 to 5 stars)

Based on 21 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Charles River Laboratories International

What analysts predicted

Upside of 15.31%

Current:

$186.65

Target:

$215.22

Insights on Charles River Laboratories International

Price Movement
In the last 7 days, CRL stock has moved up by 2.3%
Decreasing Revenue
Revenue is down for the last 2 quarters, 1.02B → 1.00B (in $), with an average decrease of 1.6% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 89.98M → 68.67M (in $), with an average decrease of 23.7% per quarter
CRL vs TMO (1 yr)
In the last 1 year, Charles River Laboratories International has experienced a drawdown of -21.8%, however Thermo Fisher Scientific, Inc. resisted the overall trend and outperformed by 21.7%
CRL vs A (3 yr)
In the last 3 years, Charles River Laboratories International has experienced a drawdown of -49.5%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 30.8%
Price to Sales
ForCRL every $1 of sales, investors are willing to pay $2.4, whereas for Thermo Fisher Scientific, Inc., the investors are paying $4.8 for every $1 of sales.

Charles River Laboratories International Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$2.3B	↑ 21.99%
Net Income	$226.4M	↑ 83.51%
Net Profit Margin	9.99%	↑ 3.35%

	FY19	Y/Y Change
Revenue	$2.6B	↑ 15.67%
Net Income	$252.0M	↑ 11.33%
Net Profit Margin	9.61%	↓ 0.38%

	FY20	Y/Y Change
Revenue	$2.9B	↑ 11.55%
Net Income	$364.3M	↑ 44.55%
Net Profit Margin	12.46%	↑ 2.85%

	FY21	Y/Y Change
Revenue	$3.5B	↑ 21.08%
Net Income	$391.0M	↑ 7.32%
Net Profit Margin	11.04%	↓ 1.42%

	FY22	Y/Y Change
Revenue	$4.0B	↑ 12.31%
Net Income	$486.2M	↑ 24.36%
Net Profit Margin	12.23%	↑ 1.19%

	FY23	Y/Y Change
Revenue	$4.1B	↑ 3.86%
Net Income	$474.6M	↓ 2.39%
Net Profit Margin	11.49%	↓ 0.74%

	Q2 FY23	Q/Q Change
Revenue	$1.1B	↑ 2.97%
Net Income	$97.0M	↓ 5.93%
Net Profit Margin	9.15%	↓ 0.87%

	Q3 FY23	Q/Q Change
Revenue	$1.0B	↓ 3.14%
Net Income	$87.4M	↓ 9.93%
Net Profit Margin	8.51%	↓ 0.64%

	Q4 FY23	Q/Q Change
Revenue	$1.0B	↓ 1.28%
Net Income	$187.1M	↑ 114.08%
Net Profit Margin	18.46%	↑ 9.95%

	Q1 FY24	Q/Q Change
Revenue	$1.0B	↓ 0.19%
Net Income	$67.3M	↓ 64.01%
Net Profit Margin	6.66%	↓ 11.8%

	Q2 FY24	Q/Q Change
Revenue	$1.0B	↑ 1.44%
Net Income	$90.0M	↑ 33.65%
Net Profit Margin	8.77%	↑ 2.11%

	Q3 FY24	Q/Q Change
Revenue	$1.0B	↓ 1.59%
Net Income	$68.7M	↓ 23.68%
Net Profit Margin	6.8%	↓ 1.97%

	FY18	Y/Y Change
Profit	$840.1M	↑ 19.61%

	FY19	Y/Y Change
Profit	$958.3M	↑ 14.08%

	FY20	Y/Y Change
Profit	$1.1B	↑ 12.02%

	FY21	Y/Y Change
Profit	$1.3B	↑ 24.32%

	FY22	Y/Y Change
Profit	$1.5B	↑ 9.59%

	FY23	Y/Y Change
Profit	$1.5B	↑ 2.73%

	Q2 FY23	Q/Q Change
Profit	$399.0M	↑ 5.65%

	Q3 FY23	Q/Q Change
Profit	$361.8M	↓ 9.31%

	Q4 FY23	Q/Q Change
Profit	$364.1M	↑ 0.62%

	Q1 FY24	Q/Q Change
Profit	$320.2M	↓ 12.06%

	Q2 FY24	Q/Q Change
Profit	$335.5M	↑ 4.77%

	Q3 FY24	Q/Q Change
Profit	$349.0M	↑ 4.04%

	FY18	Y/Y Change
Operating Cash Flow	$441.1M	↑ 39.48%
Investing Cash Flow	$-955.0M	↑ 1215.68%
Financing Cash Flow	$558.1M	↓ 367.69%

	FY19	Y/Y Change
Operating Cash Flow	$480.9M	↑ 9.02%
Investing Cash Flow	$-681.5M	↓ 28.64%
Financing Cash Flow	$231.9M	↓ 58.44%

	FY20	Y/Y Change
Operating Cash Flow	$546.6M	↑ 13.65%
Investing Cash Flow	$-601.5M	↓ 11.73%
Financing Cash Flow	$47.2M	↓ 79.63%

	FY21	Y/Y Change
Operating Cash Flow	$760.8M	↑ 39.19%
Investing Cash Flow	$-1.4B	↑ 139.04%
Financing Cash Flow	$672.6M	↑ 1323.55%

	FY22	Y/Y Change
Operating Cash Flow	$619.6M	↓ 18.55%
Investing Cash Flow	$-607.9M	↓ 57.72%
Financing Cash Flow	$-42.4M	↓ 106.3%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$148.1M	↑ 35.42%
Investing Cash Flow	$-76.6M	↓ 54.57%
Financing Cash Flow	$-71.5M	↓ 383.13%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$205.5M	↑ 38.7%
Investing Cash Flow	$-324.8M	↑ 323.95%
Financing Cash Flow	$-162.9M	↑ 127.9%

Charles River Laboratories International Technicals Summary

Sell

Neutral

Buy

Charles River Laboratories International is currently in a neutral trading position according to technical analysis indicators.

Charles River Laboratories International Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Charles River Laboratories International	-6.66%	-9.82%	-21.98%	-49.92%	22.69%
Idexx Laboratories, Inc.	-1.93%	-15.1%	-25.74%	-36.49%	58.11%
Agilent Technologies Inc.	-1.48%	4.99%	-2.63%	-14.5%	60.31%
Thermo Fisher Scientific, Inc.	1.4%	-4.34%	-0.74%	-19.29%	62.74%
Danaher Corp.	-3.38%	-7.64%	-1.02%	-28.66%	50.97%
Iqvia Holdings Inc.	-0.71%	-5.42%	-14.07%	-28.73%	30.33%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Charles River Laboratories International	23.26	23.26	2.4	10.2	0.12	0.05	NA	73.97
Idexx Laboratories, Inc.	40.0	40.0	4.35	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	30.79	30.79	2.31	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	33.1	33.1	2.0	21.7	0.13	0.05	0.0	128.08
Danaher Corp.	43.46	43.46	3.06	7.5	0.08	0.04	0.0	71.03
Iqvia Holdings Inc.	26.25	26.25	1.06	11.11	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Charles River Laboratories International	Buy	$9.5B	22.69%	23.26	10.44%
Idexx Laboratories, Inc.	Buy	$33.9B	58.11%	40.0	22.53%
Agilent Technologies Inc.	Buy	$38.9B	60.31%	30.79	21.75%
Thermo Fisher Scientific, Inc.	Buy	$202.3B	62.74%	33.1	14.48%
Danaher Corp.	Buy	$166.7B	50.97%	43.46	16.39%
Iqvia Holdings Inc.	Buy	$36.3B	30.33%	26.25	9.17%

About Charles River Laboratories International

charles river provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. #drugdiscovery #biotech #biotechnology #pharmaceuticals #cro

Organization	Charles River Laboratories International
Employees	20400
CEO	Mr. James C. Foster J.D.
Industry	Commercial Services

Management People of Charles River Laboratories International

Name	Title
Mr. James C. Foster J.D.	CEO, President & Chairman
Ms. Flavia H. Pease	Corporate Executive VP & CFO
Ms. Birgit Girshick	Corporate Executive VP & COO
Mr. Joseph W. LaPlume J.D.	Corporate Executive Vice President of Corporate Development & Strategy
Mr. William D. Barbo	Corporate Executive Vice President of Community Relations
Mr. Michael Gunnar Knell	Corporate Senior VP & Chief Accounting Officer
Prof. Julie Frearson Ph.D.	Corporate Senior VP & Chief Scientific Officer
Mr. Mark Mintz	Corporate Senior VP & Chief Information Officer
Mr. Todd Spencer	Corporate Vice President of Investor Relations
Mr. Matthew L. Daniel J.D.	Corporate Senior VP, General Counsel, Corporate Secretary & Chief Compliance Officer

Important FAQs about investing in Charles River Laboratories International from India :

What is Charles River Laboratories International share price today?

Charles River Laboratories International share price today stands at $186.65, Open: $184.89 ; Previous Close: $186.29 ; High: $187.18 ; Low: $184.49 ; 52 Week High: $275.00 ; 52 Week Low: $176.48. The stock opens at $184.89, after a previous close of $186.29. The stock reached a daily high of $187.18 and a low of $184.49, with a 52-week high of $275.00 and a 52-week low of $176.48.

Can Indians buy Charles River Laboratories International shares?

Yes, Indians can invest in the Charles River Laboratories International (CRL) from India.

With INDmoney, you can buy Charles River Laboratories International at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Charles River Laboratories International at zero transaction cost.

How can I buy Charles River Laboratories International shares from India?

It is very easy to buy Charles River Laboratories International from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Charles River Laboratories International be purchased?

Yes, you can buy fractional shares of Charles River Laboratories International with INDmoney app.

What are the documents required to start investing in Charles River Laboratories International stocks?

To start investing in Charles River Laboratories International, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Charles River Laboratories International

Today’s highest price of Charles River Laboratories International (CRL) is $187.18.

Today’s lowest price of Charles River Laboratories International (CRL) is $184.49.

What is today's market capitalisation of Charles River Laboratories International

Today's market capitalisation of Charles River Laboratories International CRL is 9.5B

What is the 52 Week High and Low Range of Charles River Laboratories International

52 Week High
$275.00
52 Week Low
$176.48

What are the historical returns of Charles River Laboratories International?

1 Month Returns
-6.66%
3 Months Returns
-9.82%
1 Year Returns
-21.98%
5 Years Returns
22.69%

Who is the Chief Executive Officer (CEO) of Charles River Laboratories International

Mr. James C. Foster J.D. is the current Chief Executive Officer (CEO) of Charles River Laboratories International.

Discover More

Explore all